statistical software release 15.1 (STATA Corporation)
STATA Corporation is a verified supplier 
90
Structured Review
STATA Corporation
statistical software release 15.1
Statistical Software Release 15.1, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+release+15%2E1/statistical+software+release+14/pm40577963-77-10-7
Average 90 stars, based on 1 article reviews
Statistical Software Release 15.1, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+release+15%2E1/statistical+software+release+14/pm40577963-77-10-7
Average 90 stars, based on 1 article reviews
statistical software release 15.1 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics. Article Snippet: Statistical analysis was conducted using StataCorp 2016 Article Title: Isopropyl alcohol inhalation versus 5-HT 3 antagonists for treatment of nausea: a meta-analysis of randomised controlled trials. Article Snippet: Article Title: Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study. Article Snippet: Statistical analyses were performed using Article Title: Socioeconomic and rural-urban inequalities in emergency department utilization during the perinatal period. Article Snippet: Objective To assess inequalities in emergency department utilization during the perinatal period across socioeconomic and rural–urban gradients in Alberta, Canada.. Methods We conducted a secondary analysis of a population-based cohort study of live-birth pregnancies in Alberta between 2011 and 2017.. Emergency department visits during pregnancy and up to 1-year postpartum were analyzed. Article Title: Pediatric Orthognathic Surgery: A NSQIP-P Comparison of Peri-Operative Factors and Outcome Differences Between Cleft and Noncleft Patients. Article Snippet: Objective: The present study aimed to investigate the risk factors, complication profiles, and clinical outcomes of cleft and noncleft patients undergoing single jaw (mandibular or LeFort 1) and bimaxillary (BSSO+ LeFort 1).. Design: Retrospective Cross-sectional Study Setting: National Surgical Quality Improvement Program database 2018–2019 Patients: Pediatric patients Interventions: Outcomes for mandibular, LeFort 1, and bimaxillary osteotomy were retrospectively evaluated for cleft and noncleft patients.. Main Outcome Measures: Multivariate logistic regression was used to determine the odds of complications and length of stay for cleft and noncleft patients undergoing single jaw and double jaw surgery. Article Title: Pediatric vital signs monitoring in hospital wards: Recognition systems and factors influencing nurses' attitudes and practices. Article Snippet: 1 Ospedale Bambino Gesù, Rome, Italy 2 Meyer Children's Hospital, Florence, Italy 3 Ospedale Regina Margherita, Città della Salute, Turin, Italy 4 ASST FBF-Sacco/Ospedale Buzzi Milan, Italy 5 IRCCS Istituto Giannina Gaslini, Genoa, Italy 6 Ospedali Riuniti, Ancona, Italy 7 Ospedale Burlo Garofalo, Trieste, Italy 8 Ospedale Giovanni XXIII, Bari, Italy 9 Ospedale Sant'Orsola Malpighi, Bologna, Italy 10 ASST, Lecco, Italy 11 Sapienza Università di Roma, Rome, Italy 12 Center of Excellence for Nursing Culture and Research (CECRI), Rome, Italy Article Title: Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023. Article Snippet: We used Article Title: [Health status of calves with and without the use of a herd-specific vaccine against Mycoplasmopsis bovis]. Article Snippet: Ziel dieser Arbeit war es, Effekte einer bestandsspezifischen Vakzine gegen Mycoplasmopsis bovis (M. bovis; der Genus-Name entspricht Mycoplasma) auf den Gesundheitsstatus von Kälbern in Schweizer Mastbetrieben zu evaluieren.. Im Vorfeld dieser Arbeit wurde von einigen Landwirten berichtet, dass sie auf ihrem Betrieb seit dem Einsatz einer bestandsspezifischen Vakzine deutlich weniger Probleme mit Kälberkrankheiten hatten als zuvor.. Um diese Aussage näher zu prüfen, wurden sechs Mastbetriebe ausgewählt, die Kälber im Alter von 3–6 Wochen aufstallten. |